South Korea-based Medyssey Co., Ltd. announced that the Company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Zenius(TM) Thoracolumbar Spinal System. Though currently available in limited release, Medyssey will launch the new Zenius(TM) System in the United States in Q4. The Zenius(TM) System is a Ti alloy 5.5 mm Rod and Thoracolumbar Pedicle Screw Construct for the surgical treatment of spinal trauma, deformity, and degenerative spinal pathologies.

Read the full story here

According to a report by heart surgeons at Washington University School of Medicine in St. Louis, the addition of one ablation in a series of ablations in the Cox-Maze procedure led to a substantial improvement in the atrial fibrillation surgical treatment outcome. Atrial fibrillation is the most common irregular heart rhythm condition that affects over two million patients in the US.